Literature DB >> 30056058

Advanced glycation end products evoke inflammatory reactions in proximal tubular cells via autocrine production of dipeptidyl peptidase-4.

Kumiko Kaifu1, Seiji Ueda2, Nobutaka Nakamura3, Takanori Matsui3, Nana Yamada-Obara1, Ryotaro Ando1, Yusuke Kaida1, Masami Nakata4, Maki Matsukuma-Toyonaga1, Yuichiro Higashimoto5, Kei Fukami1, Yusuke Suzuki2, Seiya Okuda1, Sho-Ichi Yamagishi6.   

Abstract

We have previously shown that albuminuria and renal levels of advanced glycation end products (AGEs), receptor for AGEs (RAGE), and oxidative stress are suppressed in dipeptidyl peptidase-4 (DPP-4)-deficient diabetic rats, thus suggesting the crosstalk between AGE-RAGE axis and DPP-4 in experimental diabetic nephropathy. Therefore, we examined here the role of DPP-4 in AGE-evoked inflammatory reactions in human proximal tubular cells. Proteins were extracted from proximal tubular cells, and conditioned medium was collected, both of which were subjected to western blot analysis using anti-DPP-4 antibody. RAGE-aptamer was prepared using a systemic evolution of ligands by exponential enrichment. NF-κB p65 and monocyte chemoattractant protein-1 (MCP-1) gene expression was analyzed by reverse transcription-polymerase chain reaction. AGEs significantly increased DPP-4 expression and soluble DPP-4 production by tubular cells, the latter of which was attenuated by RAGE-aptamer or an anti-oxidant, N-acetylcysteine. AGEs or DPP-4 up-regulated NF-κB p65 or MCP-1 mRNA levels in tubular cells, which were suppressed by linagliptin, an inhibitor of DPP-4. AGEs stimulated NF-κB p65 gene expression in tubular cells isolated from control rats, but not from DPP-4-deficient rats. Our present results suggest that the AGE-RAGE-mediated oxidative stress could evoke inflammatory reactions in proximal tubular cells via autocrine production of DPP-4.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AGEs; DPP-4; Diabetic nephropathy; Inflammation; Proximal tubular cells

Mesh:

Substances:

Year:  2018        PMID: 30056058     DOI: 10.1016/j.mvr.2018.07.004

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  9 in total

1.  A Dipeptidyl Peptidase-4 Inhibitor Inhibits Foam Cell Formation of Macrophages in Type 1 Diabetes via Suppression of CD36 and ACAT-1 Expression.

Authors:  Michishige Terasaki; Hironori Yashima; Yusaku Mori; Tomomi Saito; Takanori Matsui; Munenori Hiromura; Hideki Kushima; Naoya Osaka; Makoto Ohara; Tomoyasu Fukui; Tsutomu Hirano; Sho-Ichi Yamagishi
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

2.  Adiponectin improves diabetic nephropathy by inhibiting necrotic apoptosis.

Authors:  Wei Yi; Qian OuYang
Journal:  Arch Med Sci       Date:  2018-11-13       Impact factor: 3.318

Review 3.  The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy.

Authors:  Ting-Ting Chang; Jaw-Wen Chen
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 5.923

4.  Effect of Dipeptidyl-Peptidase 4 Inhibitors on Circulating Oxidative Stress Biomarkers in Patients with Type 2 Diabetes Mellitus.

Authors:  Elisabetta Bigagli; Cristina Luceri; Ilaria Dicembrini; Lorenzo Tatti; Francesca Scavone; Lisa Giovannelli; Edoardo Mannucci; Maura Lodovici
Journal:  Antioxidants (Basel)       Date:  2020-03-11

5.  Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans.

Authors:  Laurie L Baggio; Elodie M Varin; Jacqueline A Koehler; Xiemin Cao; Yuliya Lokhnygina; Susanna R Stevens; Rury R Holman; Daniel J Drucker
Journal:  Nat Commun       Date:  2020-07-28       Impact factor: 14.919

6.  Knockdown of DPP4 promotes the proliferation and the activation of the CREB/aromatase pathway in ovarian granulosa cells.

Authors:  Lina Lin; Liman Wang
Journal:  Mol Med Rep       Date:  2022-01-11       Impact factor: 2.952

Review 7.  Roles and Mechanisms of Dipeptidyl Peptidase 4 Inhibitors in Vascular Aging.

Authors:  Fen Cao; Kun Wu; Yong-Zhi Zhu; Zhong-Wu Bao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-17       Impact factor: 5.555

8.  New insights into the role of empagliflozin on diabetic renal tubular lipid accumulation.

Authors:  Hong Sun; Juan Chen; Yulin Hua; Yuyang Zhang; Zheng Liu
Journal:  Diabetol Metab Syndr       Date:  2022-08-23       Impact factor: 5.395

9.  Attenuation of diabetic kidney injury in DPP4-deficient rats; role of GLP-1 on the suppression of AGE formation by inducing glyoxalase 1.

Authors:  Mithun Kumer Sarker; Jong Han Lee; Dae Ho Lee; Kwang-Hoon Chun; Hee-Sook Jun
Journal:  Aging (Albany NY)       Date:  2020-01-06       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.